Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in Severe, Refractory Asthma
NCT00994175Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Sep 2009
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in asthma, sponsored by National Heart, Lung, and Blood Institute. Started Sep 2009; status: completed.
02
Drugs
pioglitazone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00994175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00994175.